Opill, the first over-the-counter birth control pill in the United States, is poised to change the landscape of contraceptive access. It is a progestin-only contraceptive pill and boasts an impressive 98 percent efficacy rate in preventing pregnancy, as substantiated by data submitted to the U.S. Read More...
In an encouraging development, two FDA advisory panels unanimously agreed to recommend the approval of Opill (generic name: norgestrel), an over-the-counter (OTC) birth control pill. While the FDA makes its final decision, the possible consequences of over-the-counter birth control tablets are Read More...